| Lupus eritematoso sistémico (I) ER Rubio, V Emperiale, PP Ruiz, NG Castañeda Medicine-Programa de Formación Médica Continuada Acreditado 13 (31), 1739-1750, 2021 | 16 | 2021 |
| Esclerosis sistémica NG Castañeda, ER Rubio, V Emperiale, AM Hajkhan Medicine-Programa de Formación Médica Continuada Acreditado 13 (31), 1769-1778, 2021 | 5 | 2021 |
| Retention rate of secukinumab in psoriatic arthritis: Real-world data results from a Spanish multicenter cohort M Valero-Expósito, M Martín-López, C Guillén-Astete, B Joven, ... Medicine 101 (36), e30444, 2022 | 4 | 2022 |
| Lupus eritematoso sistémico (II). Estrategia terapéutica V Emperiale, ER Rubio, JS Cuba, NG Castañeda Medicine-Programa de Formación Médica Continuada Acreditado 13 (31), 1751-1759, 2021 | 4 | 2021 |
| FRI0146 SURVIVAL OF JAK INHIBITORS: REAL-WORLD DATA FROM THE BIOBADASER III REGISTRY V Emperiale, C Sánchez-Piedra, E Cuende, P Vela-Casasempere, ... Annals of the Rheumatic Diseases 78 (Suppl 2), 744-744, 2019 | 3 | 2019 |
| Protocolo diagnóstico de las alteraciones leucocitarias en la artritis reumatoide PP Ruiz, LB Nogal, VE Emperiale, MLR Bogado, AP Gómez, MÁM Soto Medicine-Programa de Formación Médica Continuada Acreditado 12 (28), 1666-1671, 2017 | 3 | 2017 |
| FRI0448 REAL-WORLD EXPERIENCE OF SECUKINUMAB FOR PSORIATIC ARTHRITIS LM MARTIN, M Valero, V Emperiale, CM Argumánez, J Bachiller-Corral, ... Annals of the Rheumatic Diseases 78 (Suppl 2), 915-915, 2019 | 2 | 2019 |
| JAKINIB in Refractory Giant Cell Arteritis. National Multicenter Study of 15 Cases and Literature Review D Prieto-Pena, J Loricera, S Romero Yuste, A Riveros-Frutos, FJ Narvaez, ... ARTHRITIS & RHEUMATOLOGY 74, 925-927, 2022 | 1 | 2022 |
| Protocolo diagnóstico diferencial de la miositis JS Cuba, LM Tapia, V Emperiale, ER Sánchez-Mateos Medicine-Programa de Formación Médica Continuada Acreditado 13 (32), 1847-1851, 2021 | 1 | 2021 |
| Protocolo de tratamiento: embarazo y lupus eritematoso sistémico V Emperiale, AM Hajkhan, CB Heras, AP Gómez Medicine-Programa de Formación Médica Continuada Acreditado 13 (31), 1783-1788, 2021 | 1 | 2021 |
| FRI0389 EFFECTIVENESS OF BIOLOGIC THERAPY ON DISEASE ACTIVITY IN ANKYLOSING SPONDYLITIS: A BIOBADASER III OBSERVATIONAL STUDY V Emperiale, C Sánchez-Piedra, C Bohórquez, M Colazo, ... Annals of the Rheumatic Diseases 78 (Suppl 2), 879-880, 2019 | 1 | 2019 |
| FRI0402 SECUKINUMAB FOR AXIAL SPONDYLOARTHRITIS: DRUG SURVIVAL IN REAL-WORLD SETTING AND RESPONSE FACTORS CM Argumánez, V Emperiale, M Martín, M Valero, J Bachiller-Corral, ... Annals of the Rheumatic Diseases 78 (Suppl 2), 887-887, 2019 | 1 | 2019 |
| AB0701 REAL-WORLD EXPERIENCE OF SECUKINUMAB FOR AXIAL SPONDYLOARTHRITIS: SPECIFIC POPULATION CHARACTERISTICS V Emperiale, JC Esteban, CM Argumánez, J Bachiller-Corral, M Valero, ... Annals of the Rheumatic Diseases 78 (Suppl 2), 1812-1813, 2019 | 1 | 2019 |
| POS0935 HIGHER 5-YEAR SURVIVAL OF CERTOLIZUMAB PEGOL IN YOUNG WOMEN WITH AXIAL SPONDYLOARTHRITIS. BIOBADASER DATA M Moreno, C Sánchez-Piedra, V Jovani, RC Cáliz, Y Perez-Vera, ... Annals of the Rheumatic Diseases 81 (Suppl 1), 769-769, 2022 | | 2022 |
| Exposure to Industrial Pollutants and Mortality Due to Inmune-mediated Inflammatory Systemic Diseases (IMD) in Spain A Perez, A Rodriguez Perez, P Fernandez-Navarro, F Albarran, ... ARTHRITIS & RHEUMATOLOGY 73, 2183-2185, 2021 | | 2021 |
| Estimating the Weight of Rheumatologic Diseases in Mortality in Spain: Basic Cause of Death vs Multiple Cause Analysis A Perez, F Albarran, C Bohorquez, A Movasat, L Ruiz, P Pretel, ... ARTHRITIS & RHEUMATOLOGY 73, 2186-2187, 2021 | | 2021 |
| Drug Survival of Secukinumab for Axial Spondyloarthritis in a Real-World Setting Possible Response Factors C Merino Argumanez, V Emperiale, M Martin, M Valero, J Bachiller, ... ARTHRITIS & RHEUMATOLOGY 71, 2019 | | 2019 |
| FRI0448 REAL-WORLD EXPERIENCE OF SECUKINUMAB FOR PSORIATIC ARTHRITIS L Maria Martin, M Valero, V Emperiale, CM Argumánez, J Bachiller-Corral, ... Annals of the Rheumatic Diseases 78 (Suppl 2), 915-915, 2019 | | 2019 |
| SECUKINUMAB FOR AXIAL SPONDYLOARTHRITIS: DRUG SURVIVAL IN REAL-WORLD SETTING AND RESPONSE FACTORS C Merino Argumanez, V Emperiale, M Martin, M Valero, J Bachiller-Corral, ... ANNALS OF THE RHEUMATIC DISEASES 78, 887-887, 2019 | | 2019 |
| ASSOCIATION BETWEEN ULTRASOUND DIAGNOSIS AND ANALYTICAL AND SEROLOGICAL DATA IN PATIENTS WITH SUSPECTED PRIMARY SJOGREN SYNDROME L Barrio Nogal, C Bohorquez, L Ruiz, A Abbasi, A Perez Gomez, ... ANNALS OF THE RHEUMATIC DISEASES 78, 1013-1014, 2019 | | 2019 |
